Your browser doesn't support javascript.
loading
Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity.
Song, Qingxiao; Wang, Xiaoning; Wu, Xiwei; Qin, Hanjun; Li, Yingfei; Riggs, Arthur D; Martin, Paul J; Chen, Yuan-Zhong; Zeng, Defu.
Afiliação
  • Song Q; Diabetes and Metabolism Research Institute, The Beckman Research Institute of City of Hope, Duarte, CA.
  • Wang X; Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA.
  • Wu X; Fujian Medical University Center of Translational Hematology, Fujian Institute of Hematology, and Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Qin H; Diabetes and Metabolism Research Institute, The Beckman Research Institute of City of Hope, Duarte, CA.
  • Li Y; Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China.
  • Riggs AD; Department of Integrative Genomics Core, The Beckman Research Institute of City of Hope, Duarte, CA.
  • Martin PJ; Department of Integrative Genomics Core, The Beckman Research Institute of City of Hope, Duarte, CA.
  • Chen YZ; The Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China; and.
  • Zeng D; Diabetes and Metabolism Research Institute, The Beckman Research Institute of City of Hope, Duarte, CA.
Blood ; 137(16): 2243-2255, 2021 04 22.
Article em En | MEDLINE | ID: mdl-33511398

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-2 / Transplante de Células-Tronco Hematopoéticas / Efeito Enxerto vs Leucemia / Doença Enxerto-Hospedeiro / Anticorpos Monoclonais Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-2 / Transplante de Células-Tronco Hematopoéticas / Efeito Enxerto vs Leucemia / Doença Enxerto-Hospedeiro / Anticorpos Monoclonais Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article